Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal disease of the lungs. It is characterized by pulmonary and extrapulmonary comorbidities. So far, little is known as regards the prevalence of cardiovascular comorbidities in IPF patients. This study aims to...
Saved in:
Main Authors: | Mohamed F. AbdelGhany, Waleed GamalEldin Khaleel, Asmaa Omar Ahmed, Ahmad BaheyElden Ahmed, Lamees M. Bakkar |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-01-01
|
Series: | The Egyptian Journal of Bronchology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43168-025-00364-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atrial Cardiomyopathy: From Diagnosis to Treatment
by: Zheyu Liu, et al.
Published: (2025-01-01) -
Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
by: Kabita Pradhan, et al.
Published: (2025-02-01) -
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01) -
CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation
by: Mingjuan Song, MM, et al.
Published: (2025-02-01) -
Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)